Scinai Immunotherapeutics (SCNI) Amortizatization of Intangibles (2022 - 2024)
Scinai Immunotherapeutics' (SCNI) quarterly Amortizatization of Intangibles came in at $57000.0 in Q3 2024, up 2750.0% year-on-year from $2000.0 in Q4 2023, and down 50.0% quarter-over-quarter from $114000.0 in Q2 2024.
Scinai Immunotherapeutics (SCNI) Amortizatization of Intangibles (2022 - 2024) Analysis & Trends
Scinai Immunotherapeutics has disclosed Amortizatization of Intangibles across 3 years of filings, most recently posting $57000.0 for Q3 2024.
- Amortizatization of Intangibles for Q3 2024 came in at $57000.0, up 2750.0% year-over-year; the trailing twelve-month figure through Sep 2024 was $248000.0 (up 66.44% YoY), and the FY2022 annual result was $153000.0, up 3.38% from the prior year.
- Amortizatization of Intangibles came in at $57000.0 for Q3 2024 at Scinai Immunotherapeutics, down from $114000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $163000.0 in Q4 2022 to a low of -$18000.0 in Q1 2023.
- The 3-year median for Amortizatization of Intangibles is $57000.0 (2024), against an average of $56428.6.
- Peak annual rise in Amortizatization of Intangibles reached 5600.0% in 2024, while the deepest fall reached 516.67% in 2024.
- Scinai Immunotherapeutics' Amortizatization of Intangibles stood at $163000.0 in 2022, then tumbled by 98.77% to $2000.0 in 2023, then jumped by 2750.0% to $57000.0 in 2024.
- The last three Amortizatization of Intangibles figures came in at $57000.0 (Q3 2024), $114000.0 (Q2 2024), and $75000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Mar 31, 2024 | 75,000.00 |
| Mar 31, 2024 | 75,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -18,000.00 |
| Mar 31, 2023 | -18,000.00 |
| Dec 31, 2022 | 163,000.00 |
| Dec 31, 2022 | 163,000.00 |